Global Cell Separation Technologies Market Overview
The key driver impacting the cell separation technologies market is the rising number of patients suffering from chronic diseases like cancer and high technological advancements in cell separation techniques. Cell separation technologies are majorly utilized in oncology research to analyze typical cell behavior as it provides accurate cell isolations, higher purity yield, time, and cost-effectiveness. for instance, according to a WHO estimations report, globally, cancer is the second most leading cause of death. There are one in six deaths that take place due to cancer . It accounts for 9.6 million deaths in 2018. The most common cancers are Breast cancer with (2.09 million cases), Lung cancer with (2.09 million cases), Colorectal (1.80 million cases), and Prostate cancer with (1.28 million cases). Moreover, a surge in focus on personalized medicines for early detection of disease, selecting appropriate treatment, and determining the prognosis of the therapy is estimated to be a significant factor that positively impacts market growth.
According to Value Market Research, the global cell separation technologies market size was valued at around USD $8,750 million in 2020 and is estimated to grow at a CAGR of about 15% during the forecast period of 2021 to 2027.
The increasing cell therapy oriented research and development with growth in the number of initiatives taken by various governments worldwide to improve their respective domestic biotechnology industry is estimated to augment cell separation technologies demand in the forecast period. The world academy of sciences, in 2015, financing the global biotechnology industry, had accounted for us$ 180 billion and had almost doubled when compared to the 2014 funding of us$ 102.57 billion. The united states (u.s.) is the undeniable global leader in the biotechnology sector, followed by Europe. for instance, as per the Australian Department Of Health, 2021 report, the stem cell therapies mission is a research funding program that will spend $150 million over nine years to develop safe, innovative, and effective treatments reachable to all australians who require them. in 2019,AICR(American Institute for cancer research) joined one voice against cancer (ovac), an alliance of cancer-fighting organizations with the objective of increasing funding for federal cancer research programs. NIH was finally funded at $41.46 billion, with NCI(national cancer institute) getting $6.44 billion. however, the high cost of cell based research may hamper the global cell separation technologies market in the long run. also, ethical issues related to embryonic stem cell separation negatively impact market growth. the current industry trends, such as technology advancements, and growing cell therapy oriented research and development, are expected to provide market players with several market opportunities.
The cell separation technologies market is vast, with many local and global players. The key leaders follow different strategies to augment their market position, such as contracts, mergers, contracts, extending product portfolio, acquisitions, expansions, and product innovations to enhance their market share at the global level. The known players included in the report are Life Technologies (Thermo Fischer Scientific, Inc.) PluriSelect GmbH, STEMCELL Technologies, EMD Millipore, Mitenyi Biotec, PerkinElmer, GE Healthcare, and Zeiss.
In this research report, the cell separation technologies market is segmented by product, technology, application, end-user, and region.
Analysis by Product:
By Product, the report is categorized into instruments and consumables. Consumable dominates the product segment with over 60% share in 2020. It is due to the increase in investments by the major players in the development of technologically advanced consumable products. Moreover, frequent use of consumables contributing to the high demand for consumables in the forecast period.
Analysis by Technologies:
By technologies, the report is categorized into gradient centrifugation, surface markers separation, fluorescence-activated cell sorting, magnetic cell sorting, and filtration based separation. Surface marker technology is estimated to show considerable growth in the forecast period. Separation based on surface marker technology comprises two technologies: fluorescence-activated cell sorting (FACS) and magnetic-activated cell sorting (MACS). It is due to the high versatility of fluorescence-activated cell sorting (FACS) technology. Moreover, the use of fluorescence-activated cell sorting technology is considered a standard in many research and clinical labs contributing to the high demand for cell separation technologies in the forecast period.
Analysis by Application:
By applications, the report is categorized as oncology research, neuroscience research, stem cell research, microbiology, immunology research, and others. Oncology research has shown a vast growth in the forecast period. It is due to the mounting number of cancer cases across the globe. Moreover, government funding in the field of cancer research drives the demand for cell separation technologies from the oncology research segment in the forecast period.
Analysis by End-User:
By end-user, the report is categorized research laboratories & institutes, biotechnology & biopharmaceutical companies, and cell banks. The biotechnology and biopharmaceutical companies segment dominates the end-user segment with over 30% share in 2020. It is due to the increasing demand for technologically advanced cell-based therapies. Also, there is rising funding by key players in biotechnology research. Moreover, the adoption of advanced instruments and consumables in pharmaceutical and biotechnology companies for cancer research and experiments drives the market demand from biotechnology and biopharmaceutical companies in the forecast period.
Analysis by Region:
In the regional outlook of the global cell separation technologies market, the North America region dominates with a market share of 30% in 2020. The growing investments in cancer research programs by the federal government in the U.S. are driving the North America region. Moreover, the increasing occurrence of chronic diseases and the growing adoption of cell-based therapies contribute to the high growth of the cell separation technologies market across North America.
Market Segmentation covered in the Report:
- Gradient Centrifugation
- Surface Markers Separation
- Fluorescence activated cell sorting
- Magnetic cell sorting
- Filtration Based Separation
By End User
- Oncology Research
- Neuroscience Research
- Stem Cell Research
- Immunology Research
- Research laboratories & Institute
- Biotechnology & Biopharmaceutical Companies
- Cell Banks
- North America
- The Asia Pacific
- Latin America
- The Middle East and Africa
This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources, Technical Journals, Financial Reports, SEC Filings, and other different industry publications.
If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.